Two new vaccines for respiratory syncytial virus (RSV) are available this year for people aged 60 and older, as well as for those between 32 and 36 weeks pregnant. With RSV (respiratory syncytial virus) season almost in full swing, medical professionals are urging people to speak to their healthcare providers about getting vaccinated. Two vaccines, Arexvy (GSK) and Abrysvo (Pfizer), have already rolled out; both are single dose and approved for people aged 60 and older, and Abrysvo has also been approved for those between 32 and 36 weeks pregnant to help protect newborns.
Two new RSV vaccines Arexvy (GSK) and Abrysvo (Pfizer) are available and approved for people aged 60 and older; Abrysvo has also been approved for those between 32 and 36 weeks pregnant to help protect newborns. Here's what to know about side effects of the RSV vaccines, and how to decide if the shot is right for you.
Corona-News: RKI meldet 8072 Neuinfektionen und 813 Tote – NRW zieht mehr Dosen aus Biontech-Ampullen handelsblatt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from handelsblatt.com Daily Mail and Mail on Sunday newspapers.